AnalyzeDirect Chou SY, Lee YC, Chen HM, Chiang MC, Lai HL, Chang HH, Wu YC, Sun CN, Chien CL, Lin YS, Wang SC, Tung YY, Chang C, Chern Y. CGS21680 attenuates symptoms of Huntington’s disease in a transgenic mouse model. J Neurochem. April 2005;93(2):310-320.
Full Text – Open Access
Publication Date
April 2005
How Analyze was Used
“All images were processed using a manual tracing tool and edge editing function provided by ANALYZE.”
Keywords
Adenosine/analogs & derivatives/ therapeutic use
Adenosine A2 Receptor Agonists
Animals
Brain/drug effects/pathology
Disease Models, Animal
Huntington Disease/genetics/pathology/prevention & control
Male
Mice
Mice, Transgenic
Motor Activity/drug effects
Phenethylamines/therapeutic use
Author Affiliation(s)
Institute of Life Sciences, National Defense Medical Center, Taipei, Taiwan. (SYC, SCW, YC)
Institute of Biomedical Sciences, Academia Sinica, Nankang, Taipei, Taiwan. (SYC, YCL, HMC, MCC, HLL, HHC, YCW, CNS, CLC, YSL, SCW, YYT, CC, YC)
Institute of Neuroscience, National Yang-Ming University, Taipei, Taiwan. (MCC, YC)
DigiGenomics Co., Taipei, Taiwan. (YCL)
ID# 2112
Tags: Adenosine/analogs & derivatives/ therapeutic use Adenosine A2 Receptor Agonists, Animal Disease Models, Animals, Brain/drug effects/pathology, Huntington Disease/genetics/pathology/prevention & control, Male, Mice, Motor Activity/drug effects, Phenethylamines/therapeutic use, Transgenic Mice